PO104 COMPARING EFFICACY AND TOXICITY IN HR+/HER2- METASTATIC BREAST CANCER PATIENTS TREATED WITH RIBOCICLIB OR PALBOCICLIB IN COMBINATION WITH ENDOCRINE THERAPY: RESULTS FROM A SINGLE CENTER IN MEXICO.

Autor: Díaz, Andrea Maliachi, Padilla, Daniel Alejandro García, Hernández, Stefan Zilli, Salinas, Claudia Haydée Arce, Díaz, Diana Fabiola Flores, Santos, Juan Antonio Matus, Fernández, José Rodrigo Espinosa, Núñez, Carlos Arturo González, Reyes, Alexandra Garcilazo, Miranda, Alberto Alvarado, Medina, Fernando Ulises Lara, Martínez, Areli Velázquez, Agramonte, Luis André Salinas, Galicia, Julieta Santamaría, Galeana, Paula Anel Cabrera
Předmět:
Zdroj: Breast; Oct2023:Supplement 1, Vol. 71, pS50-S50, 1p
Databáze: Supplemental Index
Externí odkaz: